The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 10, 2010, Pages 2359-2370

  Majkova, Zuzana ^a   Toborek, Michal ^b   Hennig, Bernhard ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Caveolae; Endothelial cells; Environmental contaminants; Flavonoids; Nutrition

Indexed keywords

CAVEOLIN 1; FLAVONOID; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; CAVEOLA; DIET; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; FAT INTAKE; GENETICS; HUMAN; METABOLISM; MOUSE; NUTRITIONAL SCIENCE; POLLUTANT; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; CAVEOLAE; CAVEOLIN 1; DIET; DIETARY FATS; DOWN-REGULATION; ENDOTHELIAL CELLS; ENVIRONMENTAL POLLUTANTS; FLAVONOIDS; HUMANS; MICE; NUTRITIONAL SCIENCES; POLYCHLORINATED BIPHENYLS; POLYCYCLIC HYDROCARBONS, AROMATIC; SIGNAL TRANSDUCTION;

EID: 77958561806     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01064.x     Document Type: Article

References (150)

1. Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res. 2006; 47: 1597-8.
2. Xu Y, Buikema H, Van Gilst WH, et al Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. Eur J Pharmacol. 2008; 585: 256-60.
3. Mineo C, Shaul PW. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res. 2006; 70: 31-41.
4. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol. 1955; 1: 445-58.
5. Palade GE. Fine structure of blood capillaries. J Appl Phys. 1953; 24: 1424.
6. Gorodinsky A, Harris DA. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol. 1995; 129: 619-27.
7. Rothberg KG, Heuser JE, Donzell WC, et al Caveolin, a protein component of caveolae membrane coats. Cell. 1992; 68: 673-82.
8. Hill MM, Bastiani M, Luetterforst R, et al PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008; 132: 113-24.
9. Glenney JR Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989; 264: 20163-6.
10. Glenney JR Jr, Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA. 1992; 89: 10517-21.
11. Cohen AW, Hnasko R, Schubert W, et al Role of caveolae and caveolins in health and disease. Physiol Rev. 2004; 84: 1341-79.
12. Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv. 2003; 3: 445-64.
13. Razani B, Wang XB, Engelman JA, et al Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol. 2002; 22: 2329-44.
14. Schubert W, Frank PG, Razani B, et al Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem. 2001; 276: 48619-22.
15. Siddiqui SS, Siddiqui ZK, Uddin S, et al p38 MAPK activation coupled to endocytosis is a determinant of endothelial monolayer integrity. Am J Physiol Lung Cell Mol Physiol. 2007; 292: L114-24.
16. Murata M, Peranen J, Schreiner R, et al VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA. 1995; 92: 10339-43.
17. Trigatti BL, Anderson RG, Gerber GE. Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun. 1999; 255: 34-9.
18. Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol. 2008; 48: 359-91.
19. Lisanti MP, Scherer PE, Tang Z, et al Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 1994; 4: 231-5.
20. Drab M, Verkade P, Elger M, et al Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001; 293: 2449-52.
21. Razani B, Engelman JA, Wang XB, et al Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem. 2001; 276: 38121-38.
22. Hagiwara Y, Sasaoka T, Araishi K, et al Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet. 2000; 9: 3047-54.
23. Park DS, Cohen AW, Frank PG, et al Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry. 2003; 42: 15124-31.
24. Wunderlich C, Schober K, Lange SA, et al Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem Biophys Res Commun. 2006; 340: 702-8.
25. Zhao YY, Liu Y, Stan RV, et al Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA. 2002; 99: 11375-80.
26. Woodman SE, Ashton AW, Schubert W, et al Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol. 2003; 162: 2059-68.
27. Frank PG, Lee H, Park DS, et al Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24: 98-105.
28. Ju H, Zou R, Venema VJ, et al Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem. 1997; 272: 18522-5.
29. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005; 288: C494-506.
30. Wu CC, Wang SH, Kuan, II, et al OxLDL upregulates caveolin-1 expression in macrophages: role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. J Cell Biochem. 2009; 107: 460-72.
31. Farhat N, Thorin-Trescases N, Voghel G, et al Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol. 2008; 86: 761-9.
32. Fernandez-Hernando C, Yu J, Suarez Y, et al Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab. 2009; 10: 48-54.
33. Hennig B, Ettinger AS, Jandacek RJ, et al Using nutrition for intervention and prevention against environmental chemical toxicity and associated diseases. Environ Health Perspect. 2007; 115: 493-5.
34. Pope CA, 3rd, Burnett RT, Krewski D, et al Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009; 120: 941-8.
35. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect. 2007; 115: 1204-9.
36. Oesterling E, Toborek M, Hennig B. Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway. Toxicol Appl Pharmacol. 2008; 232: 309-16.
37. Hennig B, Meerarani P, Slim R, et al Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol. 2002; 181: 174-83.
38. Arsenescu V, Arsenescu RI, King V, et al Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect. 2008; 116: 761-8.
39. Noren K, Weistrand C, Karpe F. Distribution of PCB congeners, DDE, hexachlorobenzene, and methylsulfonyl metabolites of PCB and DDE among various fractions of human blood plasma. Arch Environ Contam Toxicol. 1999; 37: 408-14.
40. Busbee DL, Yoo JS, Norman JO, et al Polychlorinated biphenyl uptake and transport by lymph and plasma components. Proc Soc Exp Biol Med. 1985; 179: 116-22.
41. Tiruppathi C, Song W, Bergenfeldt M, et al Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem. 1997; 272: 25968-75.
42. Lim EJ, Majkova Z, Xu S, et al Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells. Chem Biol Interact. 2008; 176: 71-8.
43. Mink PJ, Scrafford CG, Barraj LM, et al Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007; 85: 895-909.
44. Lee KW, Lip GY. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM. 2003; 96: 465-80.
45. Yang HL, Chen WQ, Cao X, et al Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J Transl Med. 2009; 7.
46. Ma DW, Seo J, Davidson LA, et al n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 2004; 18: 1040-2.
47. Brown DA, London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes Biochem Biophys Res Commun. 1997; 240: 1-7.
48. Gafencu A, Stanescu M, Toderici AM, et al Protein and fatty acid composition of caveolae from apical plasmalemma of aortic endothelial cells. Cell Tissue Res. 1998; 293: 101-10.
49. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008; 54: 24-38.
50. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23: 168-75.
51. Murata T, Lin MI, Huang Y, et al Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med. 2007; 204: 2373-82.
52. Huang PL, Huang Z, Mashimo H, et al Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995; 377: 239-42.
53. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991; 88: 4651-5.
54. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987; 92: 639-46.
55. Shaul PW, Smart EJ, Robinson LJ, et al Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996; 271: 6518-22.
56. Prabhakar P, Cheng V, Michel T. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae. J Biol Chem. 2000; 275: 19416-21.
57. Patel HH, Tsutsumi YM, Head BP, et al Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. FASEB J. 2007; 21: 1565-74.
58. Wunderlich C, Schober K, Schmeisser A, et al The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. J Mol Cell Cardiol. 2008; 44: 938-47.
59. Bucci M, Gratton JP, Rudic RD, et al in vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000; 6: 1362-7.
60. Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996; 271: 29182-90.
61. Ashburn JH, Baveja R, Kresge N, et al Remote trauma sensitizes hepatic microcirculation to endothelin via caveolin inhibition of eNOS activity. Shock. 2004; 22: 120-30.
62. Ju H, Venema VJ, Liang H, et al Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem J. 2000; 351: 257-64.
63. Linder AE, Thakali KM, Thompson JM, et al Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta. J Pharmacol Exp Ther. 2007; 323: 78-84.
64. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336: 1066-71.
65. Feng X, Gaeta ML, Madge LA, et al Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem. 2001; 276: 8341-9.
66. Garrean S, Gao XP, Brovkovych V, et al Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol. 2006; 177: 4853-60.
67. Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 1995; 270: 14214-9.
68. Muller G, Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. Antioxid Redox Signal. 2009; 11: 1711-31.
69. Oakley FD, Smith RL, Engelhardt JF. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem. 2009; 284: 33255-64.
70. Dasari A, Bartholomew JN, Volonte D, et al Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res. 2006; 66: 10805-14.
71. Graziani A, Bricko V, Carmignani M, et al Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation. Cardiovasc Res. 2004; 64: 234-42.
72. Perrone G, Zagami M, Altomare V, et al COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Arch. 2007; 451: 1039-45.
73. Massimino ML, Griffoni C, Spisni E, et al Involvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis. Cell Signal. 2002; 14: 93-8.
74. Tran QK, Ohashi K, Watanabe H. Calcium signalling in endothelial cells. Cardiovasc Res. 2000; 48: 13-22.
75. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium. 2009; 45: 625-33.
76. 2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci USA. 1998; 95: 5009-14.
77. Murata T, Lin MI, Stan RV, et al Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J Biol Chem. 2007; 282: 16631-43.
78. 2+ entry in endothelial cells. Am J Physiol Cell Physiol. 2009; 296: C403-13.
79. 2+ influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells. Mol Pharmacol. 2006; 70: 1174-83.
80. Gratton JP, Fontana J, O'Connor DS, et al Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem. 2000; 275: 22268-72.
81. Lupu C, Goodwin CA, Westmuckett AD, et al Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol. 1997; 17: 2964-74.
82. Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res. 2009; 335: 41-7.
83. Uittenbogaard A, Everson WV, Matveev SV, et al Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex. J Biol Chem. 2002; 277: 4925-31.
84. Uittenbogaard A, Shaul PW, Yuhanna IS, et al High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem. 2000; 275: 11278-83.
85. Gustavsson P, Hogstedt C. A cohort study of Swedish capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Am J Ind Med. 1997; 32: 234-9.
86. Yang H, Zhou L, Wang Z, et al Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses Benzo(a)pyrene-accelerated atherosclerosis. Atherosclerosis. 2009; 207: 51-8.
87. Arzuaga X, Ren N, Stromberg A, et al Induction of gene pattern changes associated with dysfunctional lipid metabolism induced by dietary fat and exposure to a persistent organic pollutant. Toxicol Lett. 2009; 189: 96-101.
88. Choi W, Eum SY, Lee YW, et al PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci. 2003; 75: 47-56.
89. Majkova Z, Smart E, Toborek M, et al Up-regulation of endothelial monocyte chemoattractant protein-1 by coplanar PCB77 is caveolin-1-dependent. Toxicol Appl Pharmacol. 2009; 237: 1-7.
90. Slim R, Toborek M, Robertson LW, et al Antioxidant protection against PCB-mediated endothelial cell activation. Toxicol Sci. 1999; 52: 232-9.
91. Schlezinger JJ, Struntz WD, Goldstone JV, et al Uncoupling of cytochrome P450 1A and stimulation of reactive oxygen species production by co-planar polychlorinated biphenyl congeners. Aquat Toxicol. 2006; 77: 422-32.
92. Lu ML, Schneider MC, Zheng Y, et al Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem. 2001; 276: 13442-51.
93. Razandi M, Oh P, Pedram A, et al ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol. 2002; 16: 100-15.
94. Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology. 2009; 127: 299-311.
95. Esser C. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem Pharmacol. 2009; 77: 597-607.
96. Patel RD, Murray IA, Flaveny CA, et al Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab Invest. 2009; 89: 695-707.
97. Lim EJ, Smart EJ, Toborek M, et al The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2007; 293: H3340-7.
98. Eum SY, Andras I, Hennig B, et al NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicol Appl Pharmacol. 2009; 240: 299-305.
99. Katan MB, Zock PL, Mensink RP. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr. 1994; 60: 1017S-22S.
100. Konig A, Bouzan C, Cohen JT, et al A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med. 2005; 29: 335-46.
101. Simopoulos AP. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr. 2008; 17: 131-4.
102. Spector AA. Plasma lipid transport. Clin Physiol Biochem. 1984; 2: 123-34.
103. Conrad PA, Smart EJ, Ying YS, et al Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol. 1995; 131: 1421-33.
104. Pohl J, Ring A, Ehehalt R, et al Long-chain fatty acid uptake into adipocytes depends on lipid raft function. Biochemistry. 2004; 43: 4179-87.
105. Chapkin RS, McMurray DN, Davidson LA, et al Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr. 2008; 100: 1152-7.
106. Wang L, Lim EJ, Toborek M, et al The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism. 2008; 57: 1328-39.
107. Chapkin RS, Kim W, Lupton JR, et al Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009; 81: 187-91.
108. Li Q, Zhang Q, Wang M, et al Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys. 2007; 466: 250-9.
109. Chen W, Jump DB, Esselman WJ, et al Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2007; 48: 18-26.
110. De Caterina R, Bernini W, Carluccio MA, et al Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res. 1998; 39: 1062-70.
111. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003; 126: 1-27.
112. Wassall SR, Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids. 2008; 153: 57-63.
113. Joshipura KJ, Hu FB, Manson JE, et al The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001; 134: 1106-14.
114. Hung HC, Joshipura KJ, Jiang R, et al Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004; 96: 1577-84.
115. Joshipura KJ, Hung HC, Li TY, et al Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr. 2009; 12: 115-21.
116. Spencer JP, Abd El Mohsen MM, Minihane AM, et al Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr. 2008; 99: 12-22.
117. Kris-Etherton PM, Lefevre M, Beecher GR, et al Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr. 2004; 24: 511-38.
118. Manach C, Scalbert A, Morand C, et al Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79: 727-47.
119. D'Archivio M, Filesi C, Di Benedetto R, et al Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 2007; 43: 348-61.
120. Bertelli AA, Das DK. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol. 2009; 54: 468-76.
121. Patra SK, Rizzi F, Silva A, et al Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol. 2008; 59 Suppl 9: 217-35.
122. Zheng Y, Lim EJ, Wang L, et al Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem. 2009; 20: 202-9.
123. Woodman OL, Missen MA, Boujaoude M. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol. 2004; 44: 155-63.
124. Sobey CG, Weiler JM, Boujaoude M, et al Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: comparison with 17beta-estradiol. J Pharmacol Exp Ther. 2004; 310: 135-40.
125. Tang YB, Wang QL, Zhu BY, et al Phytoestrogen genistein supplementation increases eNOS and decreases caveolin-1 expression in ovariectomized rat hearts. Sheng Li Xue Bao. 2005; 57: 373-8.
126. Kook D, Wolf AH, Yu AL, et al The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci. 2008; 49: 1712-20.
127. Choi YJ, Arzuaga X, Kluemper CT, et al Quercetin blocks caveolae-dependent pro-inflammatory responses induced by co-planar PCBs. Environ Int. 2009. DOI: 10.1016/j.envint.2009.06.009
128. Sanchez M, Galisteo M, Vera R, et al Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 2006; 24: 75-84.
129. Lopez-Sepulveda R, Jimenez R, Romero M, et al Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension. 2008; 51: 1088-95.
130. Vera R, Jimenez R, Lodi F, et al Genistein restores caveolin-1 and AT-1 receptor expression and vascular function in large vessels of ovariectomized hypertensive rats. Menopause. 2007; 14: 933-40.
131. Vera R, Sanchez M, Galisteo M, et al Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci. 2007; 112: 183-91.
132. Palozza P, Sestito R, Picci N, et al The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis. 2008; 29: 2153-61.
133. Huhtakangas JA, Olivera CJ, Bishop JE, et al The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol. 2004; 18: 2660-71.
134. Boyan BD, Wong KL, Wang L, et al Regulation of growth plate chondrocytes by 1, 25-dihydroxyvitamin D3 requires caveolae and caveolin-1. J Bone Miner Res. 2006; 21: 1637-47.
135. Gilad LA, Schwartz B. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. J Mol Endocrinol. 2007; 38: 603-18.
136. Balazs Z, Panzenboeck U, Hammer A, et al Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem. 2004; 89: 939-50.
137. Foraker AB, Ray A, Da Silva TC, et al Dynamin 2 regulates riboflavin endocytosis in human placental trophoblasts. Mol Pharmacol. 2007; 72: 553-62.
138. Das M, Das S, Wang P, et al Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem. 2008; 22: 287-94.
139. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52: 673-751.
140. Volonte D, Zhang K, Lisanti MP, et al Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell. 2002; 13: 2502-17.
141. Hennig B, Reiterer G, Toborek M, et al Dietary fat interacts with PCBs to induce changes in lipid metabolism in mice deficient in low-density lipoprotein receptor. Environ Health Perspect. 2005; 113: 83-7.
142. Wang L, Reiterer G, Toborek M, et al Changing ratios of omega-6 to omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity in endothelial cells. Chem Biol Interact. 2008; 172: 27-38.
143. Li Q, Zhang Q, Wang M, et al Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie. 2007; 89: 169-77.
144. Foran JA, Carpenter DO, Good DH, et al Risks and benefits of seafood consumption. Am J Prev Med. 2006; 30: 438-9.
145. Hites RA, Foran JA, Schwager SJ, et al Global assessment of polybrominated diphenyl ethers in farmed and wild salmon. Environ Sci Technol. 2004; 38: 4945-9.
146. Hamilton MC, Hites RA, Schwager SJ, et al Lipid composition and contaminants in farmed and wild salmon. Environ Sci Technol. 2005; 39: 8622-9.
147. Ramadass P, Meerarani P, Toborek M, et al Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci. 2003; 76: 212-9.
148. Parton RG, Joggerst B, Simons K. Regulated internalization of caveolae. J Cell Biol. 1994; 127: 1199-215.
149. Pelkmans L, Puntener D, Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science. 2002; 296: 535-9.
150. Amakura Y, Tsutsumi T, Sasaki K, et al Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry. 2008; 69: 3117-30.